Company STAAR Surgical Company

Equities

STAA

US8523123052

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-04-18 pm EDT 5-day change 1st Jan Change
46.77 USD +0.93% Intraday chart for STAAR Surgical Company -9.36% +49.86%

Business Summary

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. These lenses provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The Company is a manufacturer of lenses used worldwide in corrective or refractive surgery. It sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom, and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux, and Italy. The Company markets and sells ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. The Company’s EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company also markets and sells an ICL lens to treat hyperopia (farsightedness), which is called Visian ICL.

Number of employees: 1,057

Sales per Business

USD in Million2022Weight2023Weight Delta
Implantable Collamer Lenses
99.1 %
270 94.8 % 319 99.1 % +18.43%
Other Surgical Products
0.6 %
5 1.8 % 2 0.6 % -63.32%
Cataract Intraocular Lenses
0.4 %
10 3.4 % 1 0.4 % -88.18%

Sales per region

USD in Million2022Weight2023Weight Delta
China
57.6 %
148 52.1 % 186 57.6 % +25.23%
Other
25.2 %
78 27.6 % 81 25.2 % +3.46%
Japan
11.9 %
43 15.2 % 38 11.9 % -10.72%
United States
5.3 %
15 5.2 % 17 5.3 % +17.32%

Managers

Managers TitleAgeSince
Chief Executive Officer 68 20-05-31
Director of Finance/CFO 51 20-07-05
Chief Operating Officer - 23-04-23
Chief Tech/Sci/R&D Officer - 23-03-31
Chief Tech/Sci/R&D Officer 62 17-09-30
Chief Tech/Sci/R&D Officer 61 15-08-18
Compliance Officer 62 12-04-04
Investor Relations Contact - -
General Counsel 50 Nov. 30
Corporate Officer/Principal - 17-10-01

Members of the board

Members of the board TitleAgeSince
Director/Board Member 59 15-12-31
Director/Board Member 55 22-06-15
Chief Executive Officer 68 20-05-31
Director/Board Member - Nov. 30
Director/Board Member 61 21-01-20
Director/Board Member 45 21-01-20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 48,865,875 48,482,482 ( 99.22 %) 0 99.22 %

Shareholders

NameEquities%Valuation
Broadwood Capital, Inc.
22.04 %
10,768,430 22.04 % 412 M $
Broadwood Capital, Inc.
21.56 %
10,537,835 21.56 % 403 M $
BlackRock Advisors LLC
15.82 %
7,730,907 15.82 % 296 M $
Vanguard Fiduciary Trust Co.
11.19 %
5,468,710 11.19 % 209 M $
Baillie Gifford & Co.
9.103 %
4,448,208 9.103 % 170 M $
1,934,438 3.959 % 74 M $
Jackson Square Partners LLC
3.469 %
1,694,992 3.469 % 65 M $
Palo Alto Investors LP
2.818 %
1,376,950 2.818 % 53 M $
Janus Henderson Investors US LLC
2.251 %
1,099,972 2.251 % 42 M $
Geode Capital Management LLC
2.167 %
1,059,000 2.167 % 41 M $

Company contact information

STAAR Surgical Co.

25651 Atlantic Ocean Drive

92630, Lake Forest

+626 303 7902

http://www.staar.com
address STAAR Surgical Company(STAA)
  1. Stock Market
  2. Equities
  3. STAA Stock
  4. Company STAAR Surgical Company